Mucopolysaccharidosis type I

Identification and characterization of mutations affecting α-L-iduronidase activity

Guey Jen Lee-Chen, Shuan Pei Lin, I. Shen Chen, Jui Hung Chang, Chyau Wen Yang, Yi Wen Chin

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Mucopolysaccharidosis type I (MPS I) is caused by a deficiency of the lysosomal enzyme α-L-iduronidase (IDUA). MPS I covers a broad spectrum of clinical severity ranging from severe Hurler syndrome through intermediate Hurler/Scheie syndrome to mild Scheie syndrome. Mutation screening was performed in two unrelated Taiwanese MPS I patients. A Hurler/Scheie patient had A79V (C to T transition in codon 79) in exon 2 and R619G (C to G transversion in codon 619) in exon 14. R619G has been shown to cause disease. Expression of A79V in COS-7 cells showed trace amounts of IDUA activity, demonstrating the deleterious nature of the mutation. A79V mutation did not cause a reduction in IDUA mRNA levels. The reduced level of IDUA protein suggests increased degradation of the mutant enzyme. A Hurler patient had 134del12 (in-frame deletion of codons 16-19 in signal peptide) in exon 1 and Q584X (C to T transition in codon 584) in exon 13. Transfection of COS-7 cells with Q584X did not yield active enzyme. Q584X mutation caused an apparent reduction in the IDUA mRNA level and no IDUA protein was detected. Conversely, 134del12 showed 124.6% of normal activity in transfected cells and a 77-kDa precursor protein was observed on Western blot, suggesting biologic activity of precursor IDUA without posttranslational cleavage. These findings provide further evidence of the molecular heterogeneity in mutations in MPS I.

Original languageEnglish
Pages (from-to)425-428
Number of pages4
JournalJournal of the Formosan Medical Association
Volume101
Issue number6
Publication statusPublished - 2002 Aug 26

Fingerprint

Iduronidase
Mucopolysaccharidosis I
Mutation
Codon
Exons
COS Cells
Enzymes
Messenger RNA
Protein Precursors
Protein Sorting Signals
Transfection
Proteins
Western Blotting

Keywords

  • Alpha-L-iduronidase mutation characterization
  • MPS 1

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mucopolysaccharidosis type I : Identification and characterization of mutations affecting α-L-iduronidase activity. / Lee-Chen, Guey Jen; Lin, Shuan Pei; Chen, I. Shen; Chang, Jui Hung; Yang, Chyau Wen; Chin, Yi Wen.

In: Journal of the Formosan Medical Association, Vol. 101, No. 6, 26.08.2002, p. 425-428.

Research output: Contribution to journalArticle

Lee-Chen, Guey Jen ; Lin, Shuan Pei ; Chen, I. Shen ; Chang, Jui Hung ; Yang, Chyau Wen ; Chin, Yi Wen. / Mucopolysaccharidosis type I : Identification and characterization of mutations affecting α-L-iduronidase activity. In: Journal of the Formosan Medical Association. 2002 ; Vol. 101, No. 6. pp. 425-428.
@article{be15155600424c978101a6e96000543d,
title = "Mucopolysaccharidosis type I: Identification and characterization of mutations affecting α-L-iduronidase activity",
abstract = "Mucopolysaccharidosis type I (MPS I) is caused by a deficiency of the lysosomal enzyme α-L-iduronidase (IDUA). MPS I covers a broad spectrum of clinical severity ranging from severe Hurler syndrome through intermediate Hurler/Scheie syndrome to mild Scheie syndrome. Mutation screening was performed in two unrelated Taiwanese MPS I patients. A Hurler/Scheie patient had A79V (C to T transition in codon 79) in exon 2 and R619G (C to G transversion in codon 619) in exon 14. R619G has been shown to cause disease. Expression of A79V in COS-7 cells showed trace amounts of IDUA activity, demonstrating the deleterious nature of the mutation. A79V mutation did not cause a reduction in IDUA mRNA levels. The reduced level of IDUA protein suggests increased degradation of the mutant enzyme. A Hurler patient had 134del12 (in-frame deletion of codons 16-19 in signal peptide) in exon 1 and Q584X (C to T transition in codon 584) in exon 13. Transfection of COS-7 cells with Q584X did not yield active enzyme. Q584X mutation caused an apparent reduction in the IDUA mRNA level and no IDUA protein was detected. Conversely, 134del12 showed 124.6{\%} of normal activity in transfected cells and a 77-kDa precursor protein was observed on Western blot, suggesting biologic activity of precursor IDUA without posttranslational cleavage. These findings provide further evidence of the molecular heterogeneity in mutations in MPS I.",
keywords = "Alpha-L-iduronidase mutation characterization, MPS 1",
author = "Lee-Chen, {Guey Jen} and Lin, {Shuan Pei} and Chen, {I. Shen} and Chang, {Jui Hung} and Yang, {Chyau Wen} and Chin, {Yi Wen}",
year = "2002",
month = "8",
day = "26",
language = "English",
volume = "101",
pages = "425--428",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "臺灣復健醫學會",
number = "6",

}

TY - JOUR

T1 - Mucopolysaccharidosis type I

T2 - Identification and characterization of mutations affecting α-L-iduronidase activity

AU - Lee-Chen, Guey Jen

AU - Lin, Shuan Pei

AU - Chen, I. Shen

AU - Chang, Jui Hung

AU - Yang, Chyau Wen

AU - Chin, Yi Wen

PY - 2002/8/26

Y1 - 2002/8/26

N2 - Mucopolysaccharidosis type I (MPS I) is caused by a deficiency of the lysosomal enzyme α-L-iduronidase (IDUA). MPS I covers a broad spectrum of clinical severity ranging from severe Hurler syndrome through intermediate Hurler/Scheie syndrome to mild Scheie syndrome. Mutation screening was performed in two unrelated Taiwanese MPS I patients. A Hurler/Scheie patient had A79V (C to T transition in codon 79) in exon 2 and R619G (C to G transversion in codon 619) in exon 14. R619G has been shown to cause disease. Expression of A79V in COS-7 cells showed trace amounts of IDUA activity, demonstrating the deleterious nature of the mutation. A79V mutation did not cause a reduction in IDUA mRNA levels. The reduced level of IDUA protein suggests increased degradation of the mutant enzyme. A Hurler patient had 134del12 (in-frame deletion of codons 16-19 in signal peptide) in exon 1 and Q584X (C to T transition in codon 584) in exon 13. Transfection of COS-7 cells with Q584X did not yield active enzyme. Q584X mutation caused an apparent reduction in the IDUA mRNA level and no IDUA protein was detected. Conversely, 134del12 showed 124.6% of normal activity in transfected cells and a 77-kDa precursor protein was observed on Western blot, suggesting biologic activity of precursor IDUA without posttranslational cleavage. These findings provide further evidence of the molecular heterogeneity in mutations in MPS I.

AB - Mucopolysaccharidosis type I (MPS I) is caused by a deficiency of the lysosomal enzyme α-L-iduronidase (IDUA). MPS I covers a broad spectrum of clinical severity ranging from severe Hurler syndrome through intermediate Hurler/Scheie syndrome to mild Scheie syndrome. Mutation screening was performed in two unrelated Taiwanese MPS I patients. A Hurler/Scheie patient had A79V (C to T transition in codon 79) in exon 2 and R619G (C to G transversion in codon 619) in exon 14. R619G has been shown to cause disease. Expression of A79V in COS-7 cells showed trace amounts of IDUA activity, demonstrating the deleterious nature of the mutation. A79V mutation did not cause a reduction in IDUA mRNA levels. The reduced level of IDUA protein suggests increased degradation of the mutant enzyme. A Hurler patient had 134del12 (in-frame deletion of codons 16-19 in signal peptide) in exon 1 and Q584X (C to T transition in codon 584) in exon 13. Transfection of COS-7 cells with Q584X did not yield active enzyme. Q584X mutation caused an apparent reduction in the IDUA mRNA level and no IDUA protein was detected. Conversely, 134del12 showed 124.6% of normal activity in transfected cells and a 77-kDa precursor protein was observed on Western blot, suggesting biologic activity of precursor IDUA without posttranslational cleavage. These findings provide further evidence of the molecular heterogeneity in mutations in MPS I.

KW - Alpha-L-iduronidase mutation characterization

KW - MPS 1

UR - http://www.scopus.com/inward/record.url?scp=0036348096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036348096&partnerID=8YFLogxK

M3 - Article

VL - 101

SP - 425

EP - 428

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 6

ER -